These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 448996

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparative study of the effect of the Progestasert TM and Gravigard IUDs on dysmenorrhoea.
    Pizarro E, Gomez-Rogers C, Rowe PJ.
    Contraception; 1979 Nov; 20(5):455-66. PubMed ID: 527341
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Risk factors for copper T IUD expulsion: an epidemiologic analysis.
    Zhang J, Feldblum PJ, Chi IC, Farr MG.
    Contraception; 1992 Nov; 46(5):427-33. PubMed ID: 1458889
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hysterographic orientation of IUDs in relation to menstrual blood loss.
    Kandil O, Aref I, El-sheikha Z, Radwan MM, El-agizi H, Hassanein MK.
    Contracept Deliv Syst; 1983 Jul; 4(3):213-7. PubMed ID: 12265365
    [Abstract] [Full Text] [Related]

  • 11. Action of a prostaglandin synthetase inhibitor on IUD associated uterine bleeding.
    Di Lieto A, Catalano D, Miranda L, Paladini A.
    Clin Exp Obstet Gynecol; 1987 Jul; 14(1):41-4. PubMed ID: 3102127
    [Abstract] [Full Text] [Related]

  • 12. Comparison of fennel and mefenamic acid for the treatment of primary dysmenorrhea.
    Namavar Jahromi B, Tartifizadeh A, Khabnadideh S.
    Int J Gynaecol Obstet; 2003 Feb; 80(2):153-7. PubMed ID: 12566188
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy of dysmenorrhea with prostaglandin synthetase inhibitors: experiences with fluproquazone].
    Kunz J, Schneider W.
    Schweiz Med Wochenschr; 1981 Sep 26; 111(39):1451-5. PubMed ID: 6794145
    [Abstract] [Full Text] [Related]

  • 17. Menstrual delay and dysfunctional uterine bleeding associated with antiprostaglandin therapy for dysmenorrhea.
    Halbert DR.
    J Reprod Med; 1983 Sep 26; 28(9):592-4. PubMed ID: 6631846
    [Abstract] [Full Text] [Related]

  • 18. Insertion and removal of intrauterine devices.
    Johnson BA.
    Am Fam Physician; 2005 Jan 01; 71(1):95-102. PubMed ID: 15663031
    [Abstract] [Full Text] [Related]

  • 19. Comparison the effect of mefenamic acid and Teucrium polium on the severity and systemic symptoms of dysmenorrhea.
    Abadian K, Keshavarz Z, Mojab F, Alavi Majd H, Abbasi NM.
    Complement Ther Clin Pract; 2016 Feb 01; 22():12-5. PubMed ID: 26850798
    [Abstract] [Full Text] [Related]

  • 20. Intrauterine pressure changes during dysmenorrhea therapy.
    Smith RP, Powell JR.
    Am J Obstet Gynecol; 1982 Jun 01; 143(3):286-92. PubMed ID: 6805330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.